Trials / Conditions / Progesterone Receptor-positive Breast Cancer

Progesterone Receptor-positive Breast Cancer

21 registered clinical trials studyying Progesterone Receptor-positive Breast Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NCT06586957	NiKang Therapeutics, Inc.	Phase 1
Terminated	A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NCT06264921	NiKang Therapeutics, Inc.	Phase 1
Recruiting	PRE-I-SPY Phase I/Ib Oncology Platform Program NCT05868226	QuantumLeap Healthcare Collaborative	Phase 1
Withdrawn	ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With NCT04602117	QuantumLeap Healthcare Collaborative	Phase 1
Terminated	A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) NCT04504916	VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Horm NCT02186470	Ohio State University Comprehensive Cancer Center	N/A
Terminated	Phase II Study of Everolimus Beyond Progression NCT02269670	Emory University	Phase 2
Terminated	Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kid NCT02273752	Emory University	Phase 2
Completed	Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metast NCT02015559	Jonsson Comprehensive Cancer Center	Phase 2
Active Not Recruiting	A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) NCT01824836	ECOG-ACRIN Cancer Research Group	N/A
Active Not Recruiting	BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer NCT01791478	Vanderbilt-Ingram Cancer Center	Phase 1
Terminated	Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid NCT01409811	City of Hope Medical Center	N/A
Completed	Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms NCT01194440	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Terminated	RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III NCT01208441	National Cancer Institute (NCI)	Phase 1
Withdrawn	Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer NCT01100489	Case Comprehensive Cancer Center	Phase 2
Completed	Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790	Abramson Cancer Center at Penn Medicine	Phase 2
Completed	F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormon NCT00602043	National Cancer Institute (NCI)	Phase 2
Terminated	Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA B NCT00194792	University of Washington	Phase 2
Completed	Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer T NCT00194779	University of Washington	Phase 2
Completed	Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cance NCT00057941	National Cancer Institute (NCI)	Phase 2
Completed	Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in NCT00003199	Fred Hutchinson Cancer Center	Phase 2